References
- Goyal M, Malik A, Mishra NK, Gaikwad SB. Idiopathic hypertrophic pachymeningitis: spectrum of the disease. Neuroradiology. 1997;39:619–623.
- Zhou Z, Li Q, Zheng J. Hypertrophic cranial pachymeningitis induced by long-term administration of nonsteroidal antiinflammatory drugs. Ann Pharmacother. 2010;44(4):755–759. doi:10.1345/aph.1M455.
- Ahmed M, Luggen M, Herman JH, et al. Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration. J Rheumatol. 2006;33:2344–2346.
- Tfelt-Hansen P, Saxena P, Dahlöf C, et al. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain. 2000;123:9–18.
- Allen M, Tosh G, Walters G, Muers M. Pleural and pericardial fibrosis after ergotamine therapy. Respir Med. 1994;88:67–69.
- Bigal ME, Tepper SJ. Ergotamine and dihydroergotamine: a review. Curr Pain Headache Rep. 2003;7:55–62.
- Silberstein S. Methysergide. Cephalalgia. 1998;18(7):421–435. doi:10.1111/j.1468-2982.1998.1807421.x.
- Alberti C. Drug-induced retroperitoneal fibrosis: short aetiopathogenetic note, from the past times of ergot-derivatives large use to currently applied bio-pharmacology. Il Giornale di chirurgia. 2015;36:187.